Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The FDA approved a new Pfizer drug for hair loss in teens.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Ocrelizumab may cause pancreatitis in some patients.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Adalimumab improved folliculitis decalvans in most patients.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Apremilast did not work for treating severe alopecia areata.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Baricitinib is the most effective treatment for alopecia areata.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.